Signal transduction of erythropoietin in endothelial cells

Kidney International

Volumn 50, Issue 2, 1996, Pages 481-488

  Haller, Hermann ^a   Christel, Constantin ^b   Dannenberg, Lutz ^b   Thiele, Peter ^b   Lindschau, Carsten ^b   Luft, Friedrich C ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ERYTHROPOIETIN; PROTEIN TYROSINE KINASE;

ARTICLE; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION;

EID: 0029789044     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.339     Document Type: Article

References (50)

1. BODE-BOGER SM, BOGER RH, KUHN M, RADERMACHER J, FROLICH JC: Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. J Cardiovasc Pharmacol 20:S25-8, 1992
2. CARAVACA F, PIZARRO JL, ARROBAS M, CUBERO JJ, GARCIA MC, PEREZ-MIRANDA M: Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients. Kidney Int 45:845-851, 1994
3. CARLINI RG, Dusso AS, OBIALO CI, ALVAREZ UM, ROTHSTEIN M: Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43:1010-1014, 1993
4. PAGEL H, JELKMANN W, WEISS C: Erythropoietin and blood pressure. Horm Metab Res 21:224, 1989
5. RAINE A, ROGER S: Effects of erythropoietin on blood pressure. Am J Kid Dis 18(Suppl 11):76-83, 1991
6. HEIDENREICH S, RAHN K, ZIDEK W: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 39:259-265, 1991
7. ANAGNOSTOU A, LIU Z, STEINER M, CHIN K, LEE ES, KESSIMIAN N, NOGUCHI CT: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978, 1994
8. TAKAYAMA K, NAGAI T, KINUGASA E, AKIZAWA T, KOSHIKAWA S: Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. Asaio Trans 37:M187-M188, 1991
9. CARLINI RG, REYES AA, ROTHSTEIN M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47:740-745, 1995
10. BARBER DL, D'ANDREA AD: The erythropoietin receptor and the molecular basis of signal transduction. Semin Hematol 29:293-304. 1992
11. LINNEKIN D, EVANS GA, D'ANDREA A, FARRAR WL: Association of the erythropoietin receptor with protein tyrosine kinase activity. Proc Natl Acad Sci USA 89:6237-6241, 1992
12. DUSANTER-FOURT I, CASADEVALL N, LACOMBE C, MULLER O, BILLAT C, FISCHER S, MAYEUX P: Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem 267:10670-10675, 1992
13. RUFF JAMISON S, CHEN K, COHEN S: Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat 5 in mouse liver. Proc Natl Acad Sci USA 92:4215-4218, 1995
14. ABDEL-LATIF AA: Calcium-mobilizing receptors, polyphosphoinositides and the generation of second-messengers. Pharmacol Rev 38:227-271, 1986
15. ROZENGURT E: Early signals in the mitogenic response. Science 234:161-166, 1986
16. MILLER BA, BELL LL, LYNCH CJ, CHEUNG JY: Erythropoietin modulation of intracellular calcium: A role for tyrosine phosphorylation. Cell Calcium 16:481-90, 1994
17. TEPEL M, WISCHNIOWSKI H, ZIDEK W: Erythropoietin increases cytosolic free calcium concentration and thrombin induced changes in cytosolic free calcium in platelets from spontaniously hypertensive rats. Biochem Biophys Res Commun 177:991-997, 1991
18. HALLER H, SCHAPER D, ZIEGLER W, PHILIPP S, KUHLMANN M, DISTLER A, LUFT F: Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension 25:511-516, 1995
19. + antiport in platelets. Transplantation 57:1516-1520, 1994
20. HALLER H, ZIEGLER W, LINDSCHAU C, LUFT FC: Endothelial cell tyrosine kinase receptor and G-protein coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vasc Biol (in press)
21. HALLER H, LINDSCHAU C, QUASS P, DISTLER A, LUFT FC: Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-α. Circ Res 76:21-29, 1995
22. HALLER H, BAUR E, QUASS P, BEHREND M, LINDSCHAU C, DISTLER A, LUFT FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47:1057-1067, 1995
23. 2+ in human endothelial cells and augments thrombin-induced cell signalling. J Lab Clin Invest 124:708-714, 1994
24. LINNEKIN D, EVANS G, MICHIEL D, FARRAR WL: Characterization of a 97-kDa phosphotyrosylprotein regulated by multiple cytokines. J Biol Chem 267:23993-23998, 1992
25. KRANTZ SB: Erythropoietin. Blood 77:419-434, 1991
26. HANAZONO Y, CHIBA S, SASAKI K, MANO H, YAZAKI Y, HIRAI H: Erythropoietin induces tyrosine phosphorylation and kinase activity of the c-fps/fes proto-oncogene product in human erythropoietin-responsive cells. Blood 81:3193-3196, 1993
27. WATOWICH SS, YOSHIMURA A, LONGMORE GD, HILTON DJ, YOSHIMURA Y, LODISH HF: Homodimerization and constitutive activation of the crythropoietin receptor. Proc Natl Acad Sci USA 89:2140-2144, 1992
28. D'ANDREA AD, JONES SS: Activation of the erythropoietin receptor in stable lymphoid and myeloid transfectants. Semin Hematol 28:152-157, 1991
29. KOCH CA, ANDERSON D, MORAN MF, ELLIS C, PAWSON T: SH2 and SH3 domains: Elements that control interactions of cytoplasmatic si/gnaling proteins. Science 252:668-674, 1991
30. JOHNSTON JA, KAWAMURA M, KIRKEN RA, CHEN YQ, BLAKE TB, SHIBUYA K, ORTALDO JR, MCVICAR DW, O'SHEA JJ: Phosphorylation and activation of the JAK-3 kinase in response to interleukin-2. Nature 370:151-153, 1994
31. DAMEN JE, MUI AL, PUIL L, PAWSON T, KRYSTAL G: Phosphatidylinositol 3-kinase associates via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81:3204-3210, 1993
32. ARGETSINGER LS, CAMPBELL GS, YANG X, WITTHUHN BA, SILVENNOINEN O, IHLE JN, CARTER-SU C: Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237-244, 1993
33. WITTHUHN BA, QUELLE FW, SILVENNOINEN O, YI T, TANG B, MIURA O, IHLE JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227-236, 1993
34. MAYEUX P, DUSANTER-FOURT I, MULLER O, MAUDTT P, SABBAH M, DRUKER B, VAINCHENKER W, FISCHER S, LACOMBE C, GISSELBRECHT S: Erythropoietin induces the association of phosphatidylinositol 3′-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. Eur J Bioehem 216:821-828, 1993
35. KOURY MJ, BONDURANT MC: The mechanism of erythropoietin action. Am J Kidney Dis 18:20-23, 1991
36. QUELLE DE, WOJCHOWSKI DM: Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 88:4801-4805, 1991
37. YOSHIMURA A, LODISH HF: In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130. Mol Cell Biol 12:706-715, 1992
38. MIURA O, CLEVELAND JL, IHLE JN: Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol Cell Biol 13:1788-1795, 1993
39. KISHIMOTO T, TAGA T, AKIRA S: Cytokine signal transduction. Cell 76:253-262, 1994
40. DAMEN J, MUI AL, HUGHES P, HUMPHRIES K, KRYSTAL G: Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line. Blood 80:1923-1932, 1992
41. ODAI H, SASAKI K, IWAMATSU A, HANAZONO Y, TANAKA T, MITANI K, YAZAKI Y, HIRAI H: The proto-oncogene product c-Cb1 becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J Biol Chem 270:10800-10805, 1995
42. MIURA Y, MIURA O, IHLE JN, AOKI N: Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962-22969, 1994
43. ANAGNOSTOU A, LEE ES, KESSIMIAN N, LEVINSON R, STEINER M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978-5982, 1990
44. FUNG M, SCEARCE R, HOFFMAN J, PEFFER N, HAMMES S, HOSKING J, SCHMANDT R, KUZIEL W, HAYNES B, MILLS GB, GREENE W: A tyrosine kinase physically associates with the β-subunit of the human IL-2 receptor. J Immunol 147:1253-1260, 1991
45. HATAKEYAMA M, KONO T, KOBAYASHI N, KAWAHARA A, LEVIN S, PERLMUTTER R, TANIGUCHI T: Science 252:1253-1528, 1991
46. WAKAO H, HARADA N, KITAMURA T, MUI AL, MIYAJIMA A: Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 14:2527-2535, 1995
47. WOOD TJ, SLIVA D, LOBIE PE, PIRCHER TJ, GOUILLEUX F, WAKAO H, GUSTAFSSON JA, GRONER B, NORSTEDT G, HALDOSEN LA: Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5. J Biol Chem 270:9448-9453, 1995
48. WAXMAN DJ, RAM PA, PARK SH, CHOI HK: Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed. Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem 270:13262-132670, 1995
49. BARAHMAND POUR F, MEINKE A, EILERS A, GOUILLEUX F, GRONER B, DECKER T: Colony-stimulating factors and interferon-gamma activate a protein related to MGF-Stat 5 to cause formation of the differentiation-induced factor in myeloid cells. FEBS Lett 360:29-33, 1995
50. BUND S, HEAGERTY A, EDMUNDS M, WALLS J: Erythropoietin does not induce vasoconstriction directly in human subcutaneous resistance arterioles. (abstract) Nephron 53:173, 1989